Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project"

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2018 Oct 21

PMID 30341678

Citations 1

Authors

Cedric Bousquet

Bissan Audeh

Florelle Bellet

Agnes Lillo-Le Louet

Affiliations

Soon will be listed here.

Citing Articles

Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.

Karapetiantz P, Audeh B, Redjdal A, Tiffet T, Bousquet C, Jaulent M J Med Internet Res. 2024; 26:e46176.

PMID: 38888956 PMC: 11220433. DOI: 10.2196/46176.

References

Ghosh R, Lewis D . Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media. Expert Opin Drug Saf. 2015; 14(12):1845-53. DOI: 10.1517/14740338.2015.1096342. View

Benton A, Ungar L, Hill S, Hennessy S, Mao J, Chung A . Identifying potential adverse effects using the web: a new approach to medical hypothesis generation. J Biomed Inform. 2011; 44(6):989-96. PMC: 4404640. DOI: 10.1016/j.jbi.2011.07.005. View

Sadah S, Shahbazi M, Wiley M, Hristidis V . A Study of the Demographics of Web-Based Health-Related Social Media Users. J Med Internet Res. 2015; 17(8):e194. PMC: 4705027. DOI: 10.2196/jmir.4308. View

Smith M, Benattia I . The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. Drug Saf. 2016; 39(9):779-85. PMC: 4982890. DOI: 10.1007/s40264-016-0426-9. View

Micoulaud-Franchi J . [One step more toward pharmacovigilance 2.0. Integration of web data community for a pharmacovigilance more alert]. Presse Med. 2011; 40(9 Pt 1):790-2. DOI: 10.1016/j.lpm.2011.07.001. View

Bouwman R, Bomhoff M, Robben P, Friele R . Patients' perspectives on the role of their complaints in the regulatory process. Health Expect. 2015; 19(2):483-96. PMC: 5055263. DOI: 10.1111/hex.12373. View

Caster O, Dietrich J, Kurzinger M, Lerch M, Maskell S, Noren G . Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. Drug Saf. 2018; 41(12):1355-1369. PMC: 6223695. DOI: 10.1007/s40264-018-0699-2. View

Inacio P, Cavaco A, Allan E, Airaksinen M . Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union. Public Health. 2018; 155:119-128. DOI: 10.1016/j.puhe.2017.11.023. View

Harpaz R, Odgers D, Gaskin G, DuMouchel W, Winnenburg R, Bodenreider O . A time-indexed reference standard of adverse drug reactions. Sci Data. 2015; 1:140043. PMC: 4306188. DOI: 10.1038/sdata.2014.43. View

10.

Inacio P, Cavaco A, Airaksinen M . Current trends in pharmacovigilance: value and gaps of patient reporting. Int J Clin Pharm. 2018; 40(4):754-757. DOI: 10.1007/s11096-018-0689-6. View

11.

Duh M, Cremieux P, Audenrode M, Vekeman F, Karner P, Zhang H . Can social media data lead to earlier detection of drug-related adverse events?. Pharmacoepidemiol Drug Saf. 2016; 25(12):1425-1433. PMC: 5157765. DOI: 10.1002/pds.4090. View

12.

Bate A, Reynolds R, Caubel P . The hope, hype and reality of Big Data for pharmacovigilance. Ther Adv Drug Saf. 2018; 9(1):5-11. PMC: 5753994. DOI: 10.1177/2042098617736422. View

13.

Golder S, Norman G, Loke Y . Systematic review on the prevalence, frequency and comparative value of adverse events data in social media. Br J Clin Pharmacol. 2015; 80(4):878-88. PMC: 4594731. DOI: 10.1111/bcp.12746. View

14.

Karapetiantz P, Bellet F, Audeh B, Lardon J, Leprovost D, Aboukhamis R . Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions. Front Pharmacol. 2018; 9:439. PMC: 5938397. DOI: 10.3389/fphar.2018.00439. View

15.

Casassus B . Risks of reformulation: French patients complain after Merck modifies levothyroxine pills. BMJ. 2018; 360:k714. DOI: 10.1136/bmj.k714. View

16.

Thiessard F, Roux E, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, Tubert-Bitter P . Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf. 2005; 28(8):731-40. DOI: 10.2165/00002018-200528080-00007. View

17.

Tricco A, Zarin W, Lillie E, Jeblee S, Warren R, Khan P . Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. BMC Med Inform Decis Mak. 2018; 18(1):38. PMC: 6001022. DOI: 10.1186/s12911-018-0621-y. View

18.

Golomb B, McGraw J, Evans M, Dimsdale J . Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007; 30(8):669-75. DOI: 10.2165/00002018-200730080-00003. View